Diagnosis and Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Pharmacology CME) - $49.00
Publication Date: October 2017 (Volume 19, Number 10)
CME Credits: 4 AMA PRA Category 1 Credits™, 4 ACEP Category I Credits, 4 AAFP Prescribed Credits, 4 AOA Category 2-A or 2-B Credits. CME expires 10/1/2020
Specialty CME Credits:: Included as part of the 4 credits, this CME activity is eligible for 1 Pharmacology CME credit, subject to your state and institutional approval.
Van Holden, MD
Pulmonary and Critical Care Fellow, Division of Pulmonary and Critical Care Medicine, University of Maryland Medical Center, Baltimore, MD
Donald Slack, III, MD
Pulmonary and Critical Care Medicine, Greater Baltimore Medical Center, Baltimore, MD
Michael T. McCurdy, MD, FCCM, FCCP, FAAEM
Associate Professor, Department of Emergency Medicine and Department of Medicine, Division of Pulmonary and Critical Care; Director, Critical Care Medicine Fellowship Program, University of Maryland School of Medicine, Baltimore, MD
Nirav G. Shah, MD, FCCP
Associate Professor of Medicine, Division of Pulmonary and Critical Care Medicine; Director, Pulmonary and Critical Care Medicine Fellowship Program, University of Maryland School of Medicine, Baltimore, MD
Gabriel Wardi, MD, MPH
Department of Emergency Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of California San Diego, San Diego, CA
Geralda Xavier, MD, MPH, FACEP
Department of Emergency Medicine, NYC Health + Hospitals, Kings County Hospital, Brooklyn, NY
Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a clinical diagnosis that is based on changes in dyspnea, cough, and/or sputum production in a COPD patient; however, patients presenting with an acute exacerbation may be undiagnosed or have a variety of comorbid conditions that can complicate diagnosis. This issue presents strategies and algorithms for the early use of evidence-based interventions, including appropriate use of antibiotics, bronchodilators, and corticosteroids, along with noninvasive ventilation with capnography, to minimize morbidity and mortality associated with this disease.
Excerpt From This Issue
It is change of shift, and you receive sign-out on a 67-year-old gentleman with a history of COPD presenting with 5 days of worsening productive cough, wheezing, and increased albuterol use despite outpatient treatment with prednisone and doxycycline. His oxygen saturation was 86% on arrival, and the nurse placed him on oxygen therapy at 6 L/min via nasal cannula shortly before you arrived. You find the patient sitting on the edge of his bed, tachypneic, with increased work of breathing and audible wheezing on auscultation. He is alert and acknowledges your presence but does not speak. You wonder why he continues to be hypoxic and if there is any other intervention that is indicated . . .
- 03/16/2018 Excellent recommendations of a common ED malady; love the Risk Management pearls in the issue.
Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.